• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Aug 19
8:00 am - 9:00 am EDT

Member Forum: Equitable Access to Care

Aug 19
6:00 pm - 7:00 pm EDT

Member Forum: Equitable Access to Care

Aug 20
11:00 am - 12:00 pm EDT

ALS-FTD Clinicopathological Overlap

Sep 8
8:00 am - 9:00 am EDT

Member Forum: Health Literacy

Sep 8
6:00 pm - 7:00 pm EDT

Member Forum: Health Literacy

View Calendar

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Frank Bos, Netherlands

    Frank Bos, Netherlands

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Animesh Kumar, India

    Animesh Kumar, India

  • Verónica Isabel Castro Molina, Argentina

    Verónica Isabel Castro Molina, Argentina

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Norm MacIsaac, Canada

    Norm MacIsaac, Canada

  • Christian Bär, Germany

    Christian Bär, Germany

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Lombana, Spain

    Lombana, Spain

  • Phil Rossall, UK

    Phil Rossall, UK

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Art Eggert, USA

    Art Eggert, USA

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Ian Gale, Australia

    Ian Gale, Australia

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Susan Anderson, USA

    Susan Anderson, USA

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Greg Heydet, USA

    Greg Heydet, USA

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Jean

    Jean
    jean

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Frank Taylor, USA

    Frank Taylor, USA

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Jon Newsome, USA

    Jon Newsome, USA

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login